Overview

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study will compare the effect of a prasugrel 10-mg maintenance dose with a clopidogrel 75-mg maintenance dose on platelet activity, approximately 1 week after the first dose of study drug, in subjects who have been taking clopidogrel 75 mg daily following a percutaneous coronary intervention (PCI) with placement of a stent, performed to treat acute coronary syndrome (ACS).
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Collaborators:
Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.
Treatments:
Clopidogrel
Prasugrel Hydrochloride
Ticlopidine